COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Ruiyuan Cao
Institution
Beijing Institute of Pharmacology and Toxicology
Address
Beijing
China
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2010
1
2011
1
2013
1
2014
1
2015
1
2016
2
2017
1
2018
3
2019
2
2020
9
2021
3
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Leng L
,
Li M
,
Li W
,
Mou D
,
Liu G
,
Ma J
,
Zhang S
,
Li H
,
Cao R
,
Zhong W
. Sera proteomic features of active and recovered COVID-19 patients: potential diagnostic and prognostic biomarkers. Signal Transduct Target Ther. 2021 06 03; 6(1):216.
PMID:
34083512
.
Citations:
2
Translation:
Humans
Mou D
,
Feng H
,
Cao R
,
Weng X
,
Zhao L
,
Yang L
,
Jin R
,
Chen W
. Profile of specific antibodies to the SARS-CoV-2. J Med Microbiol. 2021 Mar; 70(3).
PMID:
33734961
.
Citations:
Fields:
Mic
Microbiology
Translation:
Humans
Leng L
,
Cao R
,
Ma J
,
Lv L
,
Li W
,
Zhu Y
,
Wu Z
,
Wang M
,
Zhou Y
,
Zhong W
. Pathological features of COVID-19-associated liver injury-a preliminary proteomics report based on clinical samples. Signal Transduct Target Ther. 2021 01 08; 6(1):9.
PMID:
33419962
.
Citations:
3
Wang Y
,
Zhong W
,
Salam A
,
Tarning J
,
Zhan Q
,
Huang JA
,
Weng H
,
Bai C
,
Ren Y
,
Yamada K
,
Wang D
,
Guo Q
,
Fang Q
,
Tsutomu S
,
Zou X
,
Li H
,
Gillesen A
,
Castle L
,
Chen C
,
Li H
,
Zhen J
,
Lu B
,
Duan J
,
Guo L
,
Jiang J
,
Cao R
,
Fan G
,
Li J
,
Hayden FG
,
Wang C
,
Horby P
,
Cao B
. Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza. EBioMedicine. 2020 Dec; 62:103125.
PMID:
33232871
.
Citations:
6
Fields:
Gen
Genetics
Med
Medicine (General)
Translation:
Humans
CT
Clinical Trials
Leng L
,
Cao R
,
Ma J
,
Mou D
,
Zhu Y
,
Li W
,
Lv L
,
Gao D
,
Zhang S
,
Gong F
,
Zhao L
,
Qiu B
,
Xiang H
,
Hu Z
,
Feng Y
,
Dai Y
,
Zhao J
,
Wu Z
,
Li H
,
Zhong W
. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples. Signal Transduct Target Ther. 2020 10 15; 5(1):240.
PMID:
33060566
.
Citations:
29
Translation:
Humans
Cells
PH
Public Health
Fu D
,
Cao R
,
Zhao L
,
Li W
,
Zhong W
,
Wen J
. Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series. Crit Care. 2020 09 25; 24(1):578.
PMID:
32977854
.
Citations:
2
Fields:
Cri
Critical Care
Translation:
Humans
Cells
PH
Public Health
Zhang L
,
Liu J
,
Cao R
,
Xu M
,
Wu Y
,
Shang W
,
Wang X
,
Zhang H
,
Jiang X
,
Sun Y
,
Hu H
,
Li Y
,
Zou G
,
Zhang M
,
Zhao L
,
Li W
,
Guo X
,
Zhuang X
,
Yang XL
,
Shi ZL
,
Deng F
,
Hu Z
,
Xiao G
,
Wang M
,
Zhong W
. Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro. Virol Sin. 2020 Dec; 35(6):776-784.
PMID:
32910347
.
Citations:
6
Fields:
Vir
Virology
Translation:
Humans
Animals
Cells
Cao R
,
Hu H
,
Li Y
,
Wang X
,
Xu M
,
Liu J
,
Zhang H
,
Yan Y
,
Zhao L
,
Li W
,
Zhang T
,
Xiao D
,
Guo X
,
Li Y
,
Yang J
,
Hu Z
,
Wang M
,
Zhong W
. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro. ACS Infect Dis. 2020 09 11; 6(9):2524-2531.
PMID:
32786284
.
Citations:
37
Fields:
Ant
Anti-Infective Agents
Dru
Drug Therapy
Mic
Microbiology
Translation:
Animals
Cells
PH
Public Health
Wang X
,
Cao R
,
Zhang H
,
Liu J
,
Xu M
,
Hu H
,
Li Y
,
Zhao L
,
Li W
,
Sun X
,
Yang X
,
Shi Z
,
Deng F
,
Hu Z
,
Zhong W
,
Wang M
. The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro. Cell Discov. 2020; 6:28.
PMID:
32373347
.
Citations:
95
Liu J
,
Cao R
,
Xu M
,
Wang X
,
Zhang H
,
Hu H
,
Li Y
,
Hu Z
,
Zhong W
,
Wang M
. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020; 6:16.
PMID:
32194981
.
Citations:
778
Cai Q
,
Yang M
,
Liu D
,
Chen J
,
Shu D
,
Xia J
,
Liao X
,
Gu Y
,
Cai Q
,
Yang Y
,
Shen C
,
Li X
,
Peng L
,
Huang D
,
Zhang J
,
Zhang S
,
Wang F
,
Liu J
,
Chen L
,
Chen S
,
Wang Z
,
Zhang Z
,
Cao R
,
Zhong W
,
Liu Y
,
Liu L
. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering (Beijing). 2020 Oct; 6(10):1192-1198.
PMID:
32346491
.
Citations:
352
Wang M
,
Cao R
,
Zhang L
,
Yang X
,
Liu J
,
Xu M
,
Shi Z
,
Hu Z
,
Zhong W
,
Xiao G
. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 03; 30(3):269-271.
PMID:
32020029
.
Citations:
2312
Fields:
Cel
Cell Biology
Translation:
Humans
Animals
Cells
Wang C, Zhao L,
Xia S
,
Zhang T
,
Cao R
, Liang G, Li Y, Meng G, Wang W, Shi W,
Zhong W
,
Jiang S
,
Liu K
. De Novo Design of a-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. J Med Chem. 2018 10 11; 61(19):8734-8745.
PMID:
30192544
.
Citations:
13
Fields:
Che
Chemistry
Translation:
Humans
Cells
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs
Cao's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (122)
Derived automatically from this person's publications.
Artemisinins
Drug Design
Antiviral Agents
Naphthyridines
Pyrazines
Explore
_
Co-Authors (139)
People in Profiles who have published with this person.
Zhong, Wu
Wang, Manli
Leng, Ling
Xu, Mingyue
Hu, Zhihong
Explore
_
Similar People (60)
People who share similar concepts with this person.
Efferth, Thomas
White, Nicholas
Zhong, Wu
Kawaoka, Yoshihiro
Jiang, Shibo
Explore
_